Skip to search formSkip to main contentSkip to account menu

UDP-N-acetylmuramic acid pentapeptide

Known as: UDP-MurNAc-pentapeptide, UDP-N-acetylmuramyl-pentapeptide 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

UDP-N-acetylmuramic acid pentapeptidesUridine Diphosphate N-Acetylmuramic Acid
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Phase I and Pharmacokinetic Study ofTasidotin Hydrochloride ( ILX 651 ) , aThird-Generation Dolastatin-15 Analogue , AdministeredWeekly for 3 Weeks Every 28 Days in Patients with Advanced SolidTumors
Purpose: To determine the safety, tolerability, and pharmacokinetics and to seek preliminary evidence of anticancer activity of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)